RETINA: A STUDY
Date: 24/08/2022 (AEST)
Venue: Level 3, 33 MacMahon Street, Hurstville, NSW, 2220
Provider: Retina & Eye Consultants
Contact: Venus Singh, [E] venus.singh@retinaandeye.com.au, [P] 02 95701622
Learning Objectives
- Epidemiology and pathophysiology of proliferative diabetic retinopathy
- Signs and Clinical Presentations Diabetic Retinopathy
- Treatment controversy: laser or anti-VEGF injections
- Indications for surgery for Prolifertive Diabetic Retinopathy
- Understand what is a clinical trial
- Understand role of VEGF in choroidal neovascularisation
- Understand rationale and criteria for the ShORe clinical trial
- To appreciate the potential of gene therapy in Retinal disease
- Understand the basic mechanism of action
- Outline the early results of patients treated in Australia
- Become familiar with five ocular conditions in children that are generally not sinister
- Be able to distinguish benign pigmentation of the eye in infancy, from potentially sight threatening eye pigmentation .
- Understand how to check colour vision in children
- Be aware of macular conditions which should be addressed prior to cataract surgery
- Understand how macular conditions may affect the timing of cataract surgery
- Learn about the counselling of patients with both cataract and macular disease
Max CPD hours awarded: 3.75
Session Information
| Name |
|---|
| RETINA: A STUDY |
| Clinical? |
| Yes |
| Interactive? |
| Yes |
| Therapeutic? |
| Yes |
| Duration of CPD Session/Module |
| 2.5 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 3.75 |